|
1
|
Gronemeyer H, Gustafsson JA and Laudet V:
Principles for modulation of the nuclear receptor superfamily. Nat
Rev Drug Discov. 3:950–964. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nuclear Receptors Nomenclature Committee,
. A unified nomenclature system for the nuclear receptor
superfamily. Cell. 97:161–163. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Evans RM and Mangelsdorf DJ: Nuclear
receptors, RXR, and the big bang. Cell. 157:255–266. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peet DJ, Turley SD, Ma W, Janowski BA,
Lobaccaro JM, Hammer RE and Mangelsdorf DJ: Cholesterol and bile
acid metabolism are impaired in mice lacking the nuclear oxysterol
receptor LXR alpha. Cell. 93:693–704. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Apfel R, Benbrook D, Lernhardt E, Ortiz
MA, Salbert G and Pfahl M: A novel orphan receptor specific for a
subset of thyroid hormone-responsive elements and its interaction
with the retinoid/thyroid hormone receptor subfamily. Mol Cell
Biol. 14:7025–7035. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Willy PJ, Umesono K, Ong ES, Evans RM,
Heyman RA and Mangelsdorf DJ: LXR, a nuclear receptor that defines
a distinct retinoid response pathway. Genes Dev. 9:1033–1045. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shinar DM, Endo N, Rutledge SJ, Vogel R,
Rodan GA and Schmidt A: NER, a new member of the gene family
encoding the human steroid hormone nuclear receptor. Gene.
147:273–276. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang Y, Rogers PM, Stayrook KR, Su C,
Varga G, Shen Q, Nagpal S and Burris TP: The selective Alzheimer's
disease indicator-1 gene (Seladin-1/DHCR24) is a liver X receptor
target gene. Mol Pharmacol. 74:1716–1721. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cha JY and Repa JJ: The liver X receptor
(LXR) and hepatic lipogenesis. The carbohydrate-response
element-binding protein is a target gene of LXR. J Biol Chem.
282:743–751. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zelcer N and Tontonoz P: Liver X receptors
as integrators of metabolic and inflammatory signaling. J Clin
Invest. 116:607–614. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Viennois E, Pommier AJ, Mouzat K,
Oumeddour A, El Hajjaji FZ, Dufour J, Caira F, Volle DH, Baron S
and Lobaccaro JM: Targeting liver X receptors in human health:
Deadlock or promising trail? Expert Opin Ther Targets. 15:219–232.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Viennois E, Mouzat K, Dufour J, Morel L,
Lobaccaro JM and Baron S: Selective liver X receptor modulators
(SLiMs): What use in human health? Mol Cell Endocrinol.
351:129–141. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Janowski BA, Willy PJ, Devi TR, Falck JR
and Mangelsdorf DJ: An oxysterol signalling pathway mediated by the
nuclear receptor LXR alpha. Nature. 383:728–731. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Janowski BA, Grogan MJ, Jones SA, Wisely
GB, Kliewer SA, Corey EJ and Mangelsdorf DJ: Structural
requirements of ligands for the oxysterol liver X receptors
LXRalpha and LXRbeta. Proc Natl Acad Sci USA. 96:pp. 266–271. 1999;
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lehmann JM, Kliewer SA, Moore LB,
Smith-Oliver TA, Oliver BB, Su JL, Sundseth SS, Winegar DA,
Blanchard DE, Spencer TA and Willson TM: Activation of the nuclear
receptor LXR by oxysterols defines a new hormone response pathway.
J Biol Chem. 272:3137–3140. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Plat J, Nichols JA and Mensink RP: Plant
sterols and stanols: Effects on mixed micellar composition and LXR
(target gene) activation. J Lipid Res. 46:2468–2476. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jayasuriya H, Herath KB, Ondeyka JG, Guan
Z, Borris RP, Tiwari S, de Jong W, Chavez F, Moss J, Stevenson DW,
et al: Diterpenoid, steroid, and triterpenoid agonists of liver X
receptors from diversified terrestrial plants and marine sources. J
Nat Prod. 68:1247–1252. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schultz JR, Tu H, Luk A, Repa JJ, Medina
JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, et al:
Role of LXRs in control of lipogenesis. Genes Dev. 14:2831–2838.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Houck KA, Borchert KM, Hepler CD, Thomas
JS, Bramlett KS, Michael LF and Burris TP: T0901317 is a dual
LXR/FXR agonist. Mol Genet Metab. 83:184–187. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Collins JL, Fivush AM, Watson MA, Galardi
CM, Lewis MC, Moore LB, Parks DJ, Wilson JG, Tippin TK, Binz JG, et
al: Identification of a nonsteroidal liver X receptor agonist
through parallel array synthesis of tertiary amines. J Med Chem.
45:1963–1966. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Joseph SB, McKilligin E, Pei L, Watson MA,
Collins AR, Laffitte BA, Chen M, Noh G, Goodman J, Hagger GN, et
al: Synthetic LXR ligand inhibits the development of
atherosclerosis in mice. Proc Natl Acad Sci USA. 99:pp. 7604–7609.
2002; View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kaneko E, Matsuda M, Yamada Y, Tachibana
Y, Shimomura I and Makishima M: Induction of intestinal ATP-binding
cassette transporters by a phytosterol-derived liver X receptor
agonist. J Biol Chem. 278:36091–36098. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Quinet EM, Savio DA, Halpern AR, Chen L,
Miller CP and Nambi P: Gene-selective modulation by a synthetic
oxysterol ligand of the liver X receptor. J Lipid Res.
45:1929–1942. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu X, Li S, Wu J, Xia C and Lala DS: Liver
X receptors interact with corepressors to regulate gene expression.
Mol Endocrinol. 17:1019–1026. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Uno S, Endo K, Jeong Y, Kawana K, Miyachi
H, Hashimoto Y and Makishima M: Suppression of beta-catenin
signaling by liver X receptor ligands. Biochem Pharmacol.
77:186–195. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Derangère V, Chevriaux A, Courtaut F,
Bruchard M, Berger H, Chalmin F, Causse SZ, Limagne E, Végran F,
Ladoire S, et al: Liver X receptor β activation induces pyroptosis
of human and murine colon cancer cells. Cell Death Differ.
21:1914–1924. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Courtaut F, Derangère V, Chevriaux A,
Ladoire S, Cotte AK, Arnould L, Boidot R, Rialland M, Ghiringhelli
F and Rébé C: Liver X receptor ligand cytotoxicity in colon cancer
cells and not in normal colon epithelial cells depends on LXRβ
subcellular localization. Oncotarget. 6:26651–26662. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vedin LL, Gustafsson JA and Steffensen KR:
The oxysterol receptors LXRα and LXRβ suppress proliferation in the
colon. Mol Carcinog. 52:835–844. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chuu CP: Modulation of liver X receptor
signaling as a prevention and therapy for colon cancer. Med
Hypotheses. 76:697–699. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fukuchi J, Kokontis JM, Hiipakka RA, Chuu
CP and Liao S: Antiproliferative effect of liver X receptor
agonists on LNCaP human prostate cancer cells. Cancer Res.
64:7686–7689. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pommier AJ, Alves G, Viennois E, Bernard
S, Communal Y, Sion B, Marceau G, Damon C, Mouzat K, Caira F, et
al: Liver X Receptor activation downregulates AKT survival
signaling in lipid rafts and induces apoptosis of prostate cancer
cells. Oncogene. 29:2712–2723. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim KH, Lee GY, Kim JI, Ham M, Won Lee J
and Kim JB: Inhibitory effect of LXR activation on cell
proliferation and cell cycle progression through lipogenic
activity. J Lipid Res. 51:3425–3433. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Krycer JR and Brown AJ: Cross-talk between
the androgen receptor and the liver X receptor: Implications for
cholesterol homeostasis. J Biol Chem. 286:20637–20647. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fu W, Yao J, Huang Y, Li Q, Li W, Chen Z,
He F, Zhou Z and Yan J: LXR agonist regulates the carcinogenesis of
PCa via the SOCS3 pathway. Cell Physiol Biochem. 33:195–204. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gong H, Guo P, Zhai Y, Zhou J, Uppal H,
Jarzynka MJ, Song WC, Cheng SY and Xie W: Estrogen deprivation and
inhibition of breast cancer growth in vivo through activation of
the orphan nuclear receptor liver X receptor. Mol Endocrinol.
21:1781–1790. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Vedin LL, Lewandowski SA, Parini P,
Gustafsson JA and Steffensen KR: The oxysterol receptor LXR
inhibits proliferation of human breast cancer cells.
Carcinogenesis. 30:575–579. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chuu CP and Lin HP: Antiproliferative
effect of LXR agonists T0901317 and 22(R)-hydroxycholesterol on
multiple human cancer cell lines. Anticancer Res. 30:3643–3648.
2010.PubMed/NCBI
|
|
38
|
El Roz A, Bard JM, Huvelin JM and Nazih H:
LXR agonists and ABCG1-dependent cholesterol efflux in MCF-7 breast
cancer cells: Relation to proliferation and apoptosis. Anticancer
Res. 32:3007–3013. 2012.PubMed/NCBI
|
|
39
|
Nguyen-Vu T, Vedin LL, Liu K, Jonsson P,
Lin JZ, Candelaria NR, Candelaria LP, Addanki S, Williams C,
Gustafsson JÅ, et al: Liver × receptor ligands disrupt breast
cancer cell proliferation through an E2F-mediated mechanism. Breast
Cancer Res. 15:R512013. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
Candelaria NR, Addanki S, Zheng J,
Nguyen-Vu T, Karaboga H, Dey P, Gabbi C, Vedin LL, Liu K, Wu W, et
al: Antiproliferative effects and mechanisms of liver X receptor
ligands in pancreatic ductal adenocarcinoma cells. PLoS One.
9:e1062892014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang F, Stappenbeck F, Matsui W and
Parhami F: Inhibition of pancreatic cancer cell-induced paracrine
hedgehog signaling by liver X receptor agonists and Oxy16, a
naturally occurring oxysterol. J Cell Biochem. 118:499–509. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Joseph SB, Bradley MN, Castrillo A, Bruhn
KW, Mak PA, Pei L, Hogenesch J, O'connell RM, Cheng G, Saez E, et
al: LXR-dependent gene expression is important for macrophage
survival and the innate immune response. Cell. 119:299–309. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Joseph SB, Castrillo A, Laffitte BA,
Mangelsdorf DJ and Tontonoz P: Reciprocal regulation of
inflammation and lipid metabolism by liver X receptors. Nat Med.
9:213–219. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
44
|
A-Gonzalez N, Bensinger SJ, Hong C,
Beceiro S, Bradley MN, Zelcer N, Deniz J, Ramirez C, Díaz M,
Gallardo G, et al: Apoptotic cells promote their own clearance and
immune tolerance through activation of the nuclear receptor LXR.
Immunity. 31:245–258. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bensinger SJ, Bradley MN, Joseph SB,
Zelcer N, Janssen EM, Hausner MA, Shih R, Parks JS, Edwards PA,
Jamieson BD and Tontonoz P: LXR signaling couples sterol metabolism
to proliferation in the acquired immune response. Cell. 134:97–111.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang Q, Ma X, Chen Y, Zhang L, Jiang M, Li
X, Xiang R, Miao R, Hajjar DP, Duan Y and Han J: Identification of
interferon-γ as a new molecular target of liver X receptor. Biochem
J. 459:345–354. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang Q, Sun L, Yang X, Ma X, Li Q, Chen Y,
Liu Y, Zhang D, Li X, Xiang R, et al: Activation of liver X
receptor inhibits the development of pulmonary carcinomas induced
by 3-methylcholanthrene and butylated hydroxytoluene in BALB/c
mice. Sci Rep. 6:272952016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Cui G, Qin X, Wu L, Zhang Y, Sheng X, Yu
Q, Sheng H, Xi B, Zhang JZ and Zang YQ: Liver X receptor (LXR)
mediates negative regulation of mouse and human Th17
differentiation. J Clin Invest. 121:658–670. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Villablanca EJ, Raccosta L, Zhou D,
Fontana R, Maggioni D, Negro A, Sanvito F, Ponzoni M, Valentinis B,
Bregni M, et al: Tumor-mediated liver X receptor-alpha activation
inhibits CC chemokine receptor-7 expression on dendritic cells and
dampens antitumor responses. Nat Med. 16:98–105. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Feig JE, Pineda-Torra I, Sanson M, Bradley
MN, Vengrenyuk Y, Bogunovic D, Gautier EL, Rubinstein D, Hong C,
Liu J, et al: LXR promotes the maximal egress of monocyte-derived
cells from mouse aortic plaques during atherosclerosis regression.
J Clin Invest. 120:4415–4424. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Noghero A, Perino A, Seano G, Saglio E, Lo
Sasso G, Veglio F, Primo L, Hirsch E, Bussolino F and Morello F:
Liver X receptor activation reduces angiogenesis by impairing lipid
raft localization and signaling of vascular endothelial growth
factor receptor-2. Arterioscler Thromb Vasc Biol. 32:2280–2288.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Pencheva N, Buss CG, Posada J, Merghoub T
and Tavazoie SF: Broad-spectrum therapeutic suppression of
metastatic melanoma through nuclear hormone receptor activation.
Cell. 156:986–1001. 2014. View Article : Google Scholar : PubMed/NCBI
|
